Oral Oncology
Volume 46, Issue 1 , Pages 49-55, January 2010

Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins

  • Tsai-Ying Huang

      Affiliations

    • Department of Radiation Oncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Lee-Ping Hsu

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Department of Medicine, Tzu Chi University, Hualien, Taiwan
  • ,
  • Yu-Hsuan Wen

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Tung-Tsun Huang

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Department of Medicine, Tzu Chi University, Hualien, Taiwan
  • ,
  • Yu-Fu Chou

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Chia-Fong Lee

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Department of Medicine, Tzu Chi University, Hualien, Taiwan
  • ,
  • Miao-Chun Yang

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Yi-Kuo Chang

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
  • ,
  • Peir-Rong Chen

      Affiliations

    • Department of Otolaryncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Department of Medicine, Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan. Tel.: +886 3 8561825; fax: +886 3 8560977.

Received 25 August 2009; received in revised form 26 October 2009; accepted 28 October 2009. published online 14 December 2009.

Summary 

Locoregional recurrence in patients with early stage oral cavity squamous cell carcinoma (ESOSCC) after surgery remains a problem and can affect their survival. We sought to identify new high-risk factors in these patients, who need further adjuvant therapy.

We retrospectively reviewed records for 148 patients who underwent surgery for ESOSCC between 2002 and 2006 with negative surgical margins. The primary endpoint was locoregional recurrence. Recurrence-free survival (RFS) and overall survival (OS) were calculated by the Kaplan–Meier method. Univariate and multivariate analyses were used to identify independent predictors of locoregional recurrence. All patients were grouped into the low- and high-risk groups according to the odds ratios (OR) of the predictors. Recurrence rates of the low- and high-risk groups were then predicted.

Recurrence was observed in 17 of 148 (11.5%) patients at the end of this study. None of the patients received postoperative radiotherapy or chemotherapy. At 3years, the RFS rate was 89.7% and the OS rate at 3years was 84.1%. Univariate analysis of the RFS revealed three significant prognostic factors: lymphovascular permeation (LVP, p<0.001), perineural infiltration (PNI, p=0.08), and non-T4 muscular invasion (non-T4MI, p<0.005). Multivariate analysis demonstrated that LVP (p=0.007, OR=10.7) and non-T4 MI (p=0.001, OR=8.347) were independent predictors. The recurrence rate was 1.96% in patients without LVP or non-T4MI, and it increased to 26.47% in patients with non-T4MI, to 50% in patients with LVP, and to 50% in patients with both. According to the status of LVP and non-T4MI, patients were divided into two groups: low-risk (no factors present) and high-risk (one or both factors present) groups. The 2-year RFS was lower in the high-risk group (84.13%) than in the low-risk group (93.91%); the 3-year RFS was also lower in the high-risk group (70.49%) than in the low-risk group (91.99%) (p=0.008). Subgroup analysis revealed that elective neck dissections did not affect the outcome or change the pattern of failure. For patients with elective neck dissections, the RFS was lower in the high-risk group than in the low-risk group (p=0.03).

In ESOSCC (pT1-2N0), LVP and non-T4MI significantly increased the recurrence rate. The presence of one or both factors (LVP and/or non-T4MI) should be considered as a high-risk condition for locoregional recurrence, and adjuvant therapy is needed in such cases.

Keywords: Oral cavity cancer, Early stage, Recurrence, Survival, Predictor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(09)00947-6

doi:10.1016/j.oraloncology.2009.10.011

Oral Oncology
Volume 46, Issue 1 , Pages 49-55, January 2010